Review Criteria
The review committee will assess the following items for each candidate but will consider all other strengths and experiences emphasized in the applications. Items are listed by order of importance.
- Likelihood of securing an independent position in the next 1-2 years
- Dedication and research related to the 2023 Sparkathon topic; “toxicity management and mechanisms.”
- Collaboration/team player (for example through co-authoring a paper)
- Communication
- Knowledge of and experience in cancer immunotherapy
- Publications
- Appointments/varied experience so far in career
- Grants/awards received
- Presentations given
*Priority will be given to applicants who reside in and are employed at an institution located in the United States. However, international applicants may be selected based on merit.
*In alignment with SITC’s diversity, equity and inclusion strategic plan, the Sparkathon program aims to enhance diversity by increasing participation from underrepresented populations in the U.S. Biomedical Sciences according to the NIH Statement on Diversity. Priority will be given to qualified applicants who identify as an underrepresented group or from a diverse background based on self-reported data in the application.